IMARC Group has recently released a new research study “Pressure Ulcers Treatment Market : Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.
The global pressure ulcers treatment market size reached US$ 5.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach a value of US$ 6.9 Billion by 2028, exhibiting a growth rate (CAGR) of 5.18% during 2023-2028.
Pressure ulcers, also known as bedsores, are underlying tissue injuries caused by prolonged pressure and shearing forces on the skin. They usually affect the buttocks, tailbone, back, heels, elbow, shoulder, and ankles. They can be cured by preventive measures and medications that help prevent and cure deep craters with exposed muscle and bone. The treatment involves reducing pressure on the affected skin, removing necrotic tissue, controlling pain, and maintaining a moist environment for wound healing. Over the years, there has been growing awareness among individuals about the early identification and treatment of bedsores to minimize the risk of complications and prevent cancer.
The market is primarily driven by the rising geriatric population that is more susceptible to developing pressure ulcers due to skin fragility. In addition, the growing prevalence of obesity and chronic medical diseases is escalating the incidences of pressure ulcers, thus contributing to market growth.
Besides this, the leading market players are focusing on developing novel wound care products. This, coupled with the rising awareness among individuals about the early diagnosis of ulcers and the available treatment options, is positively influencing the market growth. Furthermore, the increasing numbers of hospitals, clinics, pharmacies, and drug stores across the globe and various technological advancements in the healthcare industry are also creating a favorable market outlook across the globe.
Request For Sample Report: https://www.imarcgroup.com/pressure-ulcers-treatment-market/requestsample
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
3M Company, Arjo AB, B. Braun Melsungen AG (B. Braun Holding GmbH & Co. KG), Cardinal Health Inc., Coloplast A/S, Hill-Rom Holdings Inc. (Baxter International Inc.), Invacare Corporation, Mölnlycke Health Care AB, Smith & Nephew plc, Span America (UTi Worldwide Inc.), Stiegelmeyer GmbH & Co. KG and Stryker Corporation.
The report has been segmented the market into following categories:
Breakup by Type:
- Artificial Saliva/Saliva Substitutes
- Salivary Stimulants
Breakup by Drug Type:
Breakup by Distribution Channel:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Asia Pacific
- North America
- Middle East and Africa
- Latin America
On the geographical front, Asia Pacific enjoys the leading position in the market. This can be attributed to the rising establishment of international companies in the region, on account of low manufacturing costs and cheap labor.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 |
Africa and Europe :- +44-702-409-7331 |
Asia: +91-120-433-0800, +91-120-433-0800